OTLK - Outlook Therapeutics reports Q2 results
2024-05-15 17:39:14 ET
More on Outlook Therapeutics
- Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 Approval
- Outlook Therapeutics shares rise after 'buy' rating from BTIG
- Outlook Therapeutics stock jumps as EU backs new wet AMD treatment
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics